Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Clemens

Showing results (291-300 of 434) with videos related to

Pageof 44
Sort By:
Plos Neglected Tropical Diseases|March 17, 2020
Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, BangladeshFahima Chowdhury, Taufiqur Rahman Bhuiyan, Afroza Akter, et al.
Vaccine|September 26, 2006
Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infantsFirdausi Qadri, Mohiul I Chowdhury, Shah M Faruque, et al.
BMC Research Notes|February 23, 2012
Replacing paper data collection forms with electronic data entry in the field: findings from a study of community-acquired bloodstream infections in Pemba, ZanzibarKamala Thriemer, Benedikt Ley, Shaali M Ame, et al.
The Lancet. Infectious Diseases|March 22, 2025
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trialTsiri Agbenyega, Anne E Schuind, Samuel Adjei, et al.
Bulletin of the World Health Organization|March 9, 2002
Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet NamD D Trach, P D Cam, N T Ke, et al.
International Journal of Epidemiology|October 13, 2017
Impact of adding hand-washing and water disinfection promotion to oral cholera vaccination on diarrhoea-associated hospitalization in Dhaka, Bangladesh: evidence from a cluster randomized control trialNusrat Najnin, Karin Leder, Firdausi Qadri, et al.
Plos One|November 23, 2020
Social Enterprise Model (SEM) for private sector tuberculosis screening and care in BangladeshSayera Banu, Farhana Haque, Shahriar Ahmed, et al.
Journal of Health, Population, and Nutrition|May 22, 2015
A model immunization programme to control Japanese encephalitis in Viet NamNguyen Thu Yen, Wei Liu, Hoang Duc Hanh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 5, 2020
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illnessSabeena Ahmed, Mohammad Mahbubul Karim, Allen G Ross, et al.
Plos Neglected Tropical Diseases|November 13, 2015
Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014Fahima Chowdhury, Alison E Mather, Yasmin Ara Begum, et al.
Pageof 44

Showing results (291-300 of 434) with videos related to

Sort By:
Pageof 44
Plos Neglected Tropical Diseases|March 17, 2020
Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, BangladeshFahima Chowdhury, Taufiqur Rahman Bhuiyan, Afroza Akter, et al.
Vaccine|September 26, 2006
Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infantsFirdausi Qadri, Mohiul I Chowdhury, Shah M Faruque, et al.
BMC Research Notes|February 23, 2012
Replacing paper data collection forms with electronic data entry in the field: findings from a study of community-acquired bloodstream infections in Pemba, ZanzibarKamala Thriemer, Benedikt Ley, Shaali M Ame, et al.
The Lancet. Infectious Diseases|March 22, 2025
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trialTsiri Agbenyega, Anne E Schuind, Samuel Adjei, et al.
Bulletin of the World Health Organization|March 9, 2002
Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet NamD D Trach, P D Cam, N T Ke, et al.
International Journal of Epidemiology|October 13, 2017
Impact of adding hand-washing and water disinfection promotion to oral cholera vaccination on diarrhoea-associated hospitalization in Dhaka, Bangladesh: evidence from a cluster randomized control trialNusrat Najnin, Karin Leder, Firdausi Qadri, et al.
Plos One|November 23, 2020
Social Enterprise Model (SEM) for private sector tuberculosis screening and care in BangladeshSayera Banu, Farhana Haque, Shahriar Ahmed, et al.
Journal of Health, Population, and Nutrition|May 22, 2015
A model immunization programme to control Japanese encephalitis in Viet NamNguyen Thu Yen, Wei Liu, Hoang Duc Hanh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 5, 2020
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illnessSabeena Ahmed, Mohammad Mahbubul Karim, Allen G Ross, et al.
Plos Neglected Tropical Diseases|November 13, 2015
Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014Fahima Chowdhury, Alison E Mather, Yasmin Ara Begum, et al.
Pageof 44